NovellusDx Announces It Has Completed an Equity Financing of $6 Million
Summary
NovellusDx completed a $6 million equity financing round with participation from Helsinn Investment Fund, Bio Capital Impact Fund, and Windham Venture Partners. The company has now raised nearly $17 million in total. It plans to use the new capital to accelerate commercialization, expand its functional oncology offering, and continue product development. The announcement also highlights strategic investor support and a potential deeper collaboration with Helsinn Group.
Funding
Amount
$6.0M
Total raised
Date
April 30, 2018
Announcement date
Investors
Windham Venture Partners, Bio Capital Impact Fund, Helsinn Group
Lead investors
Company
novellusdx.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected